Literature DB >> 26756635

Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Dan Shao1, Rong Tian1.   

Abstract

The heart is adapted to utilize all classes of substrates to meet the high-energy demand, and it tightly regulates its substrate utilization in response to environmental changes. Although fatty acids are known as the predominant fuel for the adult heart at resting stage, the heart switches its substrate preference toward glucose during stress conditions such as ischemia and pathological hypertrophy. Notably, increasing evidence suggests that the loss of metabolic flexibility associated with increased reliance on glucose utilization contribute to the development of cardiac dysfunction. The changes in glucose metabolism in hypertrophied hearts include altered glucose transport and increased glycolysis. Despite the role of glucose as an energy source, changes in other nonenergy producing pathways related to glucose metabolism, such as hexosamine biosynthetic pathway and pentose phosphate pathway, are also observed in the diseased hearts. This article summarizes the current knowledge regarding the regulation of glucose transporter expression and translocation in the heart during physiological and pathological conditions. It also discusses the signaling mechanisms governing glucose uptake in cardiomyocytes, as well as the changes of cardiac glucose metabolism under disease conditions.
Copyright © 2015 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26756635      PMCID: PMC4760112          DOI: 10.1002/cphy.c150016

Source DB:  PubMed          Journal:  Compr Physiol        ISSN: 2040-4603            Impact factor:   9.090


  270 in total

Review 1.  The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease.

Authors:  Natasha E Zachara
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-27       Impact factor: 4.733

Review 2.  The Metabolic Significance of the Malate-Aspartate Cycle in Heart.

Authors:  B Safer
Journal:  Circ Res       Date:  1975-11       Impact factor: 17.367

3.  Rabs 8A and 14 are targets of the insulin-regulated Rab-GAP AS160 regulating GLUT4 traffic in muscle cells.

Authors:  Shuhei Ishikura; Philip J Bilan; Amira Klip
Journal:  Biochem Biophys Res Commun       Date:  2006-12-27       Impact factor: 3.575

4.  Myocardial energy metabolism.

Authors:  L H Opie
Journal:  Adv Cardiol       Date:  1974

5.  Factors involved in GLUT-1 glucose transporter gene transcription in cardiac muscle.

Authors:  T Santalucía; K R Boheler; N J Brand; U Sahye; C Fandos; F Viñals; J Ferré; X Testar; M Palacín; A Zorzano
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

6.  Longer-term regulation of pyruvate dehydrogenase kinase in cultured rat cardiac myocytes.

Authors:  D R Marchington; A L Kerbey; P J Randle
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

7.  c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action.

Authors:  Juan C Molero; Thomas E Jensen; Phil C Withers; Michelle Couzens; Herbert Herzog; Christine B F Thien; Wallace Y Langdon; Ken Walder; Maria A Murphy; David D L Bowtell; David E James; Gregory J Cooney
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

8.  GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst.

Authors:  M O Carayannopoulos; M M Chi; Y Cui; J M Pingsterhaus; R A McKnight; M Mueckler; S U Devaskar; K H Moley
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

9.  Regional changes in creatine kinase and myocyte size in hypertensive and nonhypertensive cardiac hypertrophy.

Authors:  S H Smith; M F Kramer; I Reis; S P Bishop; J S Ingwall
Journal:  Circ Res       Date:  1990-12       Impact factor: 17.367

10.  Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.

Authors:  Robert J Sidell; Mark A Cole; Nicholas J Draper; Martine Desrois; Robin E Buckingham; Kieran Clarke
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

View more
  69 in total

1.  Cardiomyocyte cell cycling, maturation, and growth by multinucleation in postnatal swine.

Authors:  Nivedhitha Velayutham; Christina M Alfieri; Emma J Agnew; Kyle W Riggs; R Scott Baker; Sithara Raju Ponny; Farhan Zafar; Katherine E Yutzey
Journal:  J Mol Cell Cardiol       Date:  2020-07-22       Impact factor: 5.000

2.  The host response to poly(lactide-co-glycolide) scaffolds protects mice from diet induced obesity and glucose intolerance.

Authors:  Michael A Hendley; Kendall P Murphy; Christopher Isely; Heather L Struckman; Prakasam Annamalai; R Michael Gower
Journal:  Biomaterials       Date:  2019-06-19       Impact factor: 12.479

3.  Effect of delay in transportation of extracellular glucose into cardiomyocytes under diabetic condition: a study through mathematical model.

Authors:  Phonindra Nath Das; Ajay Kumar; Nandadulal Bairagi; Samrat Chatterjee
Journal:  J Biol Phys       Date:  2020-06-25       Impact factor: 1.365

Review 4.  Metabolism in cardiomyopathy: every substrate matters.

Authors:  Julia Ritterhoff; Rong Tian
Journal:  Cardiovasc Res       Date:  2017-03-15       Impact factor: 10.787

5.  Empagliflozin enhances human and murine cardiomyocyte glucose uptake by increased expression of GLUT1.

Authors:  Julian Mustroph; Charlotte M Lücht; Olivia Wagemann; Thomas Sowa; Karin P Hammer; Can M Sag; Daniel Tarnowski; Andreas Holzamer; Steffen Pabel; Bo Eric Beuthner; Samuel Sossalla; Lars S Maier; Stefan Wagner
Journal:  Diabetologia       Date:  2019-04       Impact factor: 10.122

Review 6.  Does gender influence cardiovascular remodeling in C57BL/6J mice fed a high-fat, high-sucrose and high-salt diet?

Authors:  Debora Cristina Pereira-Silva; Rayane Paula Machado-Silva; Camila Castro-Pinheiro; Caroline Fernandes-Santos
Journal:  Int J Exp Pathol       Date:  2019-07-19       Impact factor: 1.925

7.  Metabolomics assessment reveals oxidative stress and altered energy production in the heart after ischemic acute kidney injury in mice.

Authors:  Benjamin M Fox; Hyo-Wook Gil; Lara Kirkbride-Romeo; Rushita A Bagchi; Sara A Wennersten; Korey R Haefner; Nataliya I Skrypnyk; Carolyn N Brown; Danielle E Soranno; Katja M Gist; Benjamin R Griffin; Anna Jovanovich; Julie A Reisz; Matthew J Wither; Angelo D'Alessandro; Charles L Edelstein; Nathan Clendenen; Timothy A McKinsey; Christopher Altmann; Sarah Faubel
Journal:  Kidney Int       Date:  2019-01-30       Impact factor: 10.612

8.  A glucose-insulin-potassium solution improves glucose intake in hypoxic cardiomyocytes by a differential expression of glucose transporters in a metabolic syndrome model.

Authors:  R Carbo; E Rodriguez
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

Review 9.  Heart failure and diabetes: role of ATM.

Authors:  Mary C Wingard; Chad R Frasier; Mahipal Singh; Krishna Singh
Journal:  Curr Opin Pharmacol       Date:  2020-08-01       Impact factor: 5.547

Review 10.  Disruption of energy utilization in diabetic cardiomyopathy; a mini review.

Authors:  Shinsuke Nirengi; Carmem Peres Valgas da Silva; Kristin I Stanford
Journal:  Curr Opin Pharmacol       Date:  2020-09-25       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.